Ophiasis Alopecia Areata in a Patient With Spondyloarthritis on Secukinumab: A Case Report and Review of the Literature

    February 2024 in “ Curēus ”
    Christeebella O. Akpala, Yueping Zhang, Giang Huong Nguyen
    Studysummary In this case report, secukinumab therapy for spondyloarthritis was associated with the development of alopecia areata in a 46-year-old woman, which improved after discontinuing the medication.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on assets.cureus.com →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Alopecia Areata After Initiation of Secukinumab Therapy for Plaque Psoriasis Cureus · 2023
    2. The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications Cells · 2021
    3. Alopecia Diffusa While Using Interleukin-17 Inhibitors Against Psoriasis Vulgaris Case Reports in Dermatology · 2019
    4. IL-17 Inhibition: Is It the Long-Awaited Savior for Alopecia Areata? Archives of Dermatological Research · 2018